Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XB4P
|
|||
| Former ID |
DNC004224
|
|||
| Drug Name |
HTS-466284
|
|||
| Synonyms |
4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinoline; 396129-53-6; LY-364947; LY364947; 4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline; 4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE; TbetaR-I Inhibitor; LY 364947; ALK5 Inhibitor I; TGF-beta RI Kinase Inhibitor; 4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]quinoline; CHEMBL261454; Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor; 4-(3-pyridin-2-yl)(1h)-pyrazol-4-yl quinoline; 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline; [3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole; 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12N4
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=CC=N2)C3=C(NN=C3)C4=CC=CC=N4
|
|||
| InChI |
1S/C17H12N4/c1-2-6-15-13(5-1)12(8-10-19-15)14-11-20-21-17(14)16-7-3-4-9-18-16/h1-11H,(H,20,21)
|
|||
| InChIKey |
IBCXZJCWDGCXQT-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 396129-53-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
829933, 3189156, 5605932, 7890130, 11462820, 14848440, 24724526, 26759647, 36889964, 46392929, 46505424, 49700604, 50112980, 53800493, 59783971, 79396513, 85788723, 87637519, 92304770, 99302799, 103565851, 104638770, 117656320, 118854294, 125333889, 131494253, 134341429, 134964489, 135685121, 135698174, 137184515, 139739801, 144116175, 151993643, 152159645, 160644605, 160966995, 162011994, 162023546, 162201853, 162507927, 163563914, 163687208, 164225087, 164767278, 172819978, 174529262, 175607443, 178102672, 179208038
|
|||
| ChEBI ID |
CHEBI:91198
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6050). | |||
| REF 3 | Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity vers... J Med Chem. 2006 Mar 23;49(6):2138-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.